No current evidence for widespread dosage compensation in S. cerevisiae
Author(s)
Springer, Michael; Torres, Eduardo M.; Amon, Angelika B
DownloadTorres-2016-No current evidence.pdf (4.043Mb)
OPEN_ACCESS_POLICY
Open Access Policy
Creative Commons Attribution-Noncommercial-Share Alike
Terms of use
Metadata
Show full item recordAbstract
Previous studies of laboratory strains of budding yeast had shown that when gene copy number is altered experimentally, RNA levels generally scale accordingly. This is true when the copy number of individual genes or entire chromosomes is altered. In a recent study, Hose et al. (2015) reported that this tight correlation between gene copy number and RNA levels is not observed in recently isolated wild Saccharomyces cerevisiae variants. To understand the origins of this proposed difference in gene expression regulation between natural variants and laboratory strains of S. cerevisiae, we evaluated the karyotype and gene expression studies performed by Hose et al. on wild S. cerevisiae strains. In contrast to the results of Hose et al., our reexamination of their data revealed a tight correlation between gene copy number and gene expression. We conclude that widespread dosage compensation occurs neither in laboratory strains nor in natural variants of S. cerevisiae.
Date issued
2016-03Department
Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MITJournal
eLife
Publisher
eLife Sciences Publications, Ltd.
Citation
Torres, Eduardo M., Michael Springer, and Angelika Amon. "No current evidence for widespread dosage compensation in S. cerevisiae." eLife 2016;5:e10996
Version: Final published version
ISSN
2050-084X